Skip to main content

Advertisement

Table 1 Demographics of patients with MDD who receive initial treatment with SSRI monotherapy

From: What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

Characteristic Initial treatment with SSRI (N = 5,012)
Gender; n (%)  
 Female 3,267 (65.2)
 Male 1,745 (34.8)
Age; mean (SD) 41.9 (15.3)
Age distribution in years; n (%)  
 18–24 773 (15.4)
 25–34 948 (18.9)
 35–44 1,164 (23.2)
 45–54 1,110 (22.1)
 55–64 722 (14.4)
 65+ 295 (5.9)
Plan type; n (%)  
 CDHP 174 (3.5)
 COMP 224 (4.5)
 EPO 78 (1.6)
 HMO 1,233 (24.8)
 Non-capitated POS 449 (9.0)
 POS with capitation 9 (0.2)
 PPO 2,696 (54.3)
 Missing/unknown 99 (2.0)
Region; n (%)  
 Northeast 718 (14.3)
 North central 1,324 (26.4)
 South 1,431 (28.6)
 West 1,526 (30.4)
 Unknown 13 (0.3)
Charlson comorbidity index; mean (SD), median 0.5 (1.1), 0.0
Chronic disease score; mean (SD), median 2.1 (2.5), 1.0
  1. CDHP consumer-driven health insurance, COMP comprehensive medical insurance, EPO exclusive provider organization, HMO health maintenance organization, POS point of service, PPO preferred provider organization.